Treace Medical Concepts, Inc. (TMCI) Stock Analysis
A live, multi-source view of Treace Medical Concepts, Inc. (TMCI): real-time price, technical indicators, Wall Street analyst consensus, recent news sentiment and social buzz — aggregated into one place so you can size up the stock at a glance.
About Treace Medical Concepts, Inc.
Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty System, enables surgeons to correct all three dimensions of the bunion deformity, stabilize the first TMT joint, and allow return to weight-bearing in a walking boot; minimally invasive products for four bunion classes; Nanoplasty 3D Minimally Invasive Bunion Correction System delivers a reproducible 3D correction of the bunion deformity through a cosmetically appealing; and Percuplasty Percutaneous 3D Bunion Correction System that provides 3D correction of the bunion deformity through percutaneous incisions. It also provides Adductoplasty System, a system designed for the correction of metatarsus adductus deformities and osteoarthritis of the midfoot; SpeedMTP Rapid Compression Implant; SpeedPlate Implant Fixation Platform to address the fusion of larger bones of the midfoot and rearfoot; SpeedPlate Micro-Quad implant, an implant designed for stability and fit in small incision surgical approaches; and SpeedAkin Anatomic Compression Implant.
Sector: Healthcare · Industry: Medical Devices · United States · 450 employees · treace.com
Key statistics · as of 2026-09-06
As of 2026-09-06, Treace Medical Concepts, Inc. (TMCI) had a market capitalization of $312.8M (forward -5.7) and a beta of 1.41; the shares traded in a 52-week range of $1.17 – $7.63 (-32.3% over the year).
- Market cap
- $312.8M
- Enterprise value
- $340.2M
- Forward P/E
- -5.7
- Price / book
- 4.62
- EPS (trailing)
- $-0.92
- EPS (forward)
- $-0.85
- Payout ratio
- 0.0%
- 52-week range
- $1.17 – $7.63
- 52-week change
- -32.3%
- Beta
- 1.41
- Average volume
- 642,141
- Shares outstanding
- 65.0M
- Short % of float
- 3.08%
- Profit margin
- -29.0%
Fundamental figures are recorded once every few days, dated above; they are not live and can differ from the interactive tiles.
Last universe scan · 2026-09-10
In RapidTradeView’s 2026-09-10 scan of the US universe, Treace Medical Concepts, Inc. (TMCI) last closed at $4.53 (the last completed close before that scan).
Technicals at the scan: RSI 49 (neutral territory), price -1.9% versus its 20-day average, 20-day versus 50-day average spread +3.6%, MACD histogram -0.02.
Sentiment inputs: StockTwits 90% bullish; analyst consensus score 45/100.
Next scheduled company event: in 56 days from the scan date.
Scan values are recorded once per trading day and are not live quotes; the interactive tiles above update in real time.
Smart Money · last 90 days
Members of Congress disclosed 0 buys and 0 sells of TMCI; corporate insiders filed 3 buys and 0 sells (1 filer, latest disclosure 2026-08-24). Filings arrive days to weeks after the trade and are not a live signal. Most active filers: John T. Treace (3B/0S). Who is trading what
RapidTradeView pick record
TMCI has not appeared in the daily picks yet. Full scoreboard
What this page covers
RapidTradeView pulls Treace Medical Concepts, Inc. (TMCI) data from multiple independent sources and combines it into a single dashboard. Below the summary you’ll find live, interactive tiles for each of the following:
- Price & chart — real-time quote with pre/post-market moves and a line or candlestick chart.
- Technical indicators — RSI, MACD, moving averages, Bollinger Bands, volume and support/resistance, distilled into one overall signal.
- Analyst consensus — the buy/hold/sell breakdown and price targets published by Wall Street analysts.
- News sentiment — recent headlines, each scored for tone so the prevailing narrative is obvious.
- Earnings — current EPS, year-over-year change and the next scheduled earnings date.
- Social buzz — Reddit mention volume and StockTwits sentiment for the retail-trader angle.
How to read the signals
No single indicator tells the whole story. A bullish technical reading paired with a cautious analyst consensus, or strong social buzz against weak earnings, is exactly the kind of tension this view is built to surface. RapidTradeView’s signals are generated by deterministic, statistical models — they describe what the data is doing, they are not personalised recommendations to buy or sell TMCI.
Disclaimer: RapidTradeView is an educational sentiment-aggregation tool, not a licensed financial adviser, broker, or dealer. Nothing here is financial, investment, tax, or legal advice. Markets are risky and you can lose money. Always do your own research and consult a qualified professional before making any investment decision.